ACTRN12618000321246: A Phase II Study of Panobinostat in Paediatric, Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma, Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma. |
|
|
| Active, not recruiting | 2 | 60 | | | Australian and New Zealand Children’s Haematology and Oncology Group (ANZCHOG), NHMRC | Osteosarcoma, Malignant Rhabdoid Tumour, Neuroblastoma, Atypical Teratoid/Rhabdoid Tumour (AT/RT) | | | | |
| Terminated | 1 | 4 | US | Marizomib, salinosporamide A, salinosporin A, Panobinostat, Farydak | Dana-Farber Cancer Institute, Celgene, Secura Bio, Inc. | Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent, Pediatric Cancer, Pediatric Brain Tumor, Diffuse Glioma | 02/24 | 02/24 | | |
